Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 26, 2022; 10(18): 6021-6031
Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6021
Table 3 Apparent diffusion coefficient values by histopathological results, in relation to the 1.20 × 10-3 mm2/s cut-off point, among the 95 lesions evaluated (mean ± SD)
Histopathological results
Number of lesions

< 1.20 × 10-3 mm2/s, n (%)
≥ 1.20 × 10-3 mm2/s, n (%)
Benign461.42 ± 0.249 (19.6)37 (80.4)
Fibrocystic hyperplasia191.44 ± 0.324 (21.1)15 (78.9)
Fibroadenoma71.49 ± 0.272 (28.6)5 (71.4)
Adenopathy131.38 ± 0.262 (15.4)11 (84.6)
Catheter dilatation21.69 ± 0.361 (50.0)1 (50.0)
Inflammation51.16 ± 0.083 (60.0)2 (40.0)
Malignant491.08 ± 0.3035 (71.4)14 (28.6)
Ductal carcinoma in situ161.24 ± 0.259 (56.3)7 (43.7)
Invasive ductal carcinoma240.92 ± 0.2321 (87.5)3 (12.5)
Invasive lobular carcinoma51.16 ± 0.193 (60.0)2 (40.0)
Neuroendocrine carcinoma30.95 ± 0.672 (66.7)1 (33.3)
Invasive mucinous carcinoma11.84 ± 0.560 (0)1 (100)